Using nanoparticles to carry and delivery anticancer drugs holds much promise in cancer
therapy, but nanoparticles per se are lacking specificity. Active targeting, that is, using …

The non-specificity of standard anticancer therapies has profound detrimental
consequences in clinical treatment. Therapeutic specificity can be precisely achieved using …

Aptamers have attracted the attention of many researchers because of their high stability,
high affinity and high selectivity. Over the past decades, considerable intensive exploration …

Since the discovery of aptamer, aptamer has become an exciting and promising diagnostic
and therapeutic tool because of its excellent targeting selectivity, high potential affinity …

Non-small cell lung cancer (NSCLC) is one of the most prevalent cancers diagnosed
worldwide, yet managing it is still challenging. The epidermal growth factor receptor (EGFR) …

To evaluate the chemotherapeutic efficacy of J591 fabricated poly (d, l)-lactic-co-glycolic
acid (PLGA) nanoparticles containing paclitaxel (Ab-PTX-NP) in vitro in PSMA (prostate …

Prostate cancer (PCa) is one of the fatal illnesses among males globally. PCa-treatment
does not include radiotherapy. Chemotherapy eventually causes drug resistance, disease …

In the present study, the effectiveness of paclitaxel nanocrystals (PTX NCs) encapsulated in
carboxymethyl chitosan (CMCS) nanoparticles (CMCS− PTX NPs) as an anticancer drug is …

Cancer is a major cause of human death all over the world. Traditional cancer treatments
include surgery, radiotherapy, chemotherapy, immunotherapy, and hormone therapy …

Targeted drug delivery has become attention in chemotherapy during the last decade. The
principle of chemotherapy seeks maximum effect to the desired site and the minimum impact …